Skip to main content

Table 2 Our cerebral infarction cases

From: Cerebral infarction in advanced non-small cell lung cancer: a case control study

 

Age ranges

Stage

Histology

Brain metastasis at diagnosis

Number of cerebral infarctions

Anticancer therapy

Chemotherapeutic regimen

D-dimer

Outcome

OS from CI (days)

1

70s

IV

Ad

Multi

+

Erlotinib

2.2

Recover

791

2

50s

rec

Ad

Multi

+

DTX

5.6

Recover

341

3

60s

IV

Ad

+

Multi

+

CBDCA + PTX

4.9

Recover

280

4

60s

IIIB

Sq

Multi

+

CBDCA + PTX

4.6

Recover

161

5

70s

IV

Ad

+

Multi

+

Erlotinib

24.7

Recover

125

6

60s

IV

Sq

+

Mono

+

RTx

1.8

Dead

66

7

70s

IV

Ad

+

Multi

37.8

Recover

44

8

40s

IV

Ad

+

Multi

+

Erlotinib

10

Dead

36

9

50s

IV

Ad

+

Multi

+

Crizotinib

46

Dead

32

10

60s

IV

La

+

Multi

+

DTX

46.6

Dead

28

11

50s

IV

Ad

+

Mono

+

CDDP + PEM

2.8

Dead

25

12

60s

rec

Ad

Mono

+

CBDCA + PTX

60

Recover

17

13

70s

IV

Ad

+

Multi

+

RTx

22.3

Dead

7

14

70s

IV

Ad

Mono

+

PEM

141

Dead

1

15

50s

rec

Ad

+

Mono

+

CDDP + PEM

11.3

Dead

1

  1. rec recurrence, Ad adenocarcinoma, Sq squamous cell carcinoma, DTX docetaxel, CBDCA carboplatin, PTX paclitaxel, CDDP cisplatin, PEM pemetrexed, RTx radiation therapy